Detalhe da pesquisa
1.
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Int J Cancer
; 145(10): 2692-2700, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30927251
2.
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Br J Cancer
; 118(8): 1123-1129, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29555990
3.
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
Int J Mol Sci
; 19(9)2018 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30134598
4.
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Hum Mol Genet
; 24(20): 5955-64, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26231222
5.
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.
Breast Cancer Res Treat
; 166(1): 217-226, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28702895
6.
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.
BMC Cancer
; 17(1): 620, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874143
7.
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Proc Natl Acad Sci U S A
; 111(42): 15172-7, 2014 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25288723
8.
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.
Int J Cancer
; 139(12): 2760-2770, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542569
9.
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
Hum Genet
; 135(7): 741-56, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27075448
10.
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
Gynecol Oncol
; 136(3): 542-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25528498
11.
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Hum Genet
; 133(5): 481-97, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190013
12.
RAD51C is a susceptibility gene for ovarian cancer.
Hum Mol Genet
; 20(16): 3278-88, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21616938
13.
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.
J Med Genet
; 49(7): 429-32, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22652533
14.
NTHL1 is a recessive cancer susceptibility gene.
Sci Rep
; 13(1): 21127, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036545
15.
Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients.
BMC Cancer
; 12: 552, 2012 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23176254
16.
Variants on the promoter region of PTEN affect breast cancer progression and patient survival.
Breast Cancer Res
; 13(6): R130, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22171747
17.
New VOUS in CASK Gene Correlating with the MICPCH Phenotype.
Maedica (Bucur)
; 16(1): 135-139, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34221169
18.
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
J Natl Cancer Inst
; 112(12): 1242-1250, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107557
19.
Screening of HELQ in breast and ovarian cancer families.
Fam Cancer
; 15(1): 19-23, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26351136
20.
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
Int J Epidemiol
; 45(5): 1619-1630, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27594614